Clin2
NCT06197295Possibly a fitRecruiting

Combination therapy for overactive bladder in women

Urinary Bladder, OveractiveEffect of Drug

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study compares the effectiveness of a combination of medications (solifenacin and mirabegron) versus solifenacin alone with a vaginal estrogen cream for treating women with overactive bladder. It may help those who haven't improved with single medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
200 people
Ages
40 years to 90 years
Study type
Interventional

Who can take part

  • You are a woman with overactive bladder, specifically having involuntary bladder contractions.
  • You have not improved enough with only one type of medication (antimuscarinics).
  • You do not have trouble emptying your bladder completely after urination.
  • You do not have medical conditions like narrow-angle glaucoma or uncontrolled high blood pressure that prevent use of the trial drugs.
  • You have no history of conditions that prevent using estrogen, such as breast cancer, blood clots, or gallbladder disease.
  • You have not used hormone replacement therapy in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06479720Recruiting· Phase 4
Combination medications plus estrogen for overactive bladder

This trial tests whether adding estrogen therapy to a combination of two bladder medications works better than the medications alone for women with overactive bladder that hasn't improved with standard treatment.

Taipei
NCT07114640Not yet recruiting· Phase 3
Nighttime bladder medication study for overactive bladder in women

This study compares four different medications taken at bedtime to see which works best for reducing nighttime urination and improving bladder symptoms, sexual function, and blood flow to the bladder in women with overactive bladder syndrome.

Banqiao District, New Taipei
NCT05968885Recruiting· Phase 4
Compare Botox and combination medicines for overactive bladder

This study tests whether Botox injections work better than a combination of medicines (anti-muscarinics plus a beta-3 medicine) for people whose overactive bladder symptoms did not improve with one medicine alone. It may help by improving bladder control and reducing urgent, hard-to-hold urine leaks or frequent urination.

Taipei
NCT07366918Recruiting
Comparing two types of electrical stimulation for overactive bladder

This study compares two non-invasive treatments for overactive bladder (sudden, frequent urges to pee) in women who haven't gotten relief from standard medications. One treatment uses a vaginal probe, the other uses pads on the perineum (area between the vagina and anus). Both aim to calm the bladder muscles.

Denizli
NCT07025642Recruiting
Overactive Bladder Treatments for Women

This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.

New Taipei City
NCT07429734Not yet recruiting· Phase 3
Two medicines for overactive bladder in women

This study tests whether taking two medications together — gabapentin and solifenacin — helps reduce the strong, sudden urge to urinate and urine leaks in women with overactive bladder. It may offer a new treatment option that works better than current ones.

Al Mansurah

Hear when a new Urinary Bladder, Overactive trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.